Effects of an Evidence Service on Community-based AIDS Service Organizations' Use of Research Evidence
NCT ID: NCT01257724
Last Updated: 2011-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
58 participants
INTERVENTIONAL
2011-03-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods/design The investigators will conduct a two-arm randomized controlled trial (RCT), along with a follow-up qualitative process study to explore the findings in greater depth. All community-based organizations affiliated with Canadian AIDS Society (n=120) will be invited to participate and will be randomized to receive either the "full-serve" version of SHARE or the "self-serve" version (a listing of relevant systematic reviews with links to records on PubMed and worksheets that help community-based organizations find and use research evidence) using a simple randomized design. All management and staff from each organization will be provided access to the version of SHARE that their organization is allocated to. The trial duration will be 10 months (two-month baseline period, six-month intervention period, and two month cross-over period), the primary outcome measure will be the mean number of logins/month/organization (averaged across the number of users from each organization) between baseline and the end of the intervention period and the secondary outcome will be intention to use research evidence as measured by a survey administered to one key decision-maker from each organization. For the qualitative study, one key organizational decision-maker from 15 organizations in each trial arm (n=30) will be purposively sampled. One-on-one semi-structured interviews will be conducted by telephone on their views about and their experiences with the evidence service they received, how helpful it was in their work, why it was helpful (or not helpful), what aspects were most and least helpful and why, and recommendations for next steps.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Full-serve evidence service
The full-serve evidence service consists of:
1. an online searchable database of HIV-relevant systematic reviews;
2. monthly email updates highlighting new reviews;
3. access to user-friendly summaries produced by us or by others (when available);
4. links to scientific abstracts;
5. peer relevance assessments, which involves periodic requests to complete a brief assessment of how useful the information in the newly added review is with the average score posted once an assessment is completed;
6. an interface for participants to leave comments in the records of systematic reviews in the database;
7. links to full-text articles (when publicly available); and
8. access to worksheets that help CBOs find and use research evidence
SHARE (Synthesized HIV/AIDS Research Evidence)
SHARE (Synthesized HIV/AIDS Research Evidence) consists of several components:
1. an online searchable database of HIV-relevant systematic reviews;
2. monthly email updates highlighting new reviews;
3. access to user-friendly summaries produced by us or by others (when available);
4. links to scientific abstracts;
5. peer relevance assessments, which involves periodic requests to complete a brief assessment of how useful the information in the newly added review is with the average score posted once an assessment is completed;
6. an interface for participants to leave comments in the records of systematic reviews in the database;
7. links to full-text articles (when publicly available); and
8. access to worksheets that help CBOs find and use research evidence
Self-serve evidence service
Organizations allocated to the control group will only be provided website access to a listing of systematic reviews that are organized by year of publication with links to the record on PubMed (or another publicly available source when not available on PubMed) and access to worksheets that help community-based organizations find and use research evidence.
SHARE (Synthesized HIV/AIDS Research Evidence)
SHARE (Synthesized HIV/AIDS Research Evidence) consists of several components:
1. an online searchable database of HIV-relevant systematic reviews;
2. monthly email updates highlighting new reviews;
3. access to user-friendly summaries produced by us or by others (when available);
4. links to scientific abstracts;
5. peer relevance assessments, which involves periodic requests to complete a brief assessment of how useful the information in the newly added review is with the average score posted once an assessment is completed;
6. an interface for participants to leave comments in the records of systematic reviews in the database;
7. links to full-text articles (when publicly available); and
8. access to worksheets that help CBOs find and use research evidence
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SHARE (Synthesized HIV/AIDS Research Evidence)
SHARE (Synthesized HIV/AIDS Research Evidence) consists of several components:
1. an online searchable database of HIV-relevant systematic reviews;
2. monthly email updates highlighting new reviews;
3. access to user-friendly summaries produced by us or by others (when available);
4. links to scientific abstracts;
5. peer relevance assessments, which involves periodic requests to complete a brief assessment of how useful the information in the newly added review is with the average score posted once an assessment is completed;
6. an interface for participants to leave comments in the records of systematic reviews in the database;
7. links to full-text articles (when publicly available); and
8. access to worksheets that help CBOs find and use research evidence
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McMaster University
OTHER
Ontario HIV Treatment Network
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael G. Wilson
Scientist, Health Policy & Knowledge Transfer and Exchange
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael G Wilson, PhD
Role: PRINCIPAL_INVESTIGATOR
McMaster University; Ontario HIV Treatment Network
John N Lavis, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
McMaster University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ontario HIV Treatment Network
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wilson MG, Lavis JN, Grimshaw JM, Haynes RB, Bekele T, Rourke SB. Effects of an evidence service on community-based AIDS service organizations' use of research evidence: a protocol for a randomized controlled trial. Implement Sci. 2011 May 27;6:52. doi: 10.1186/1748-5908-6-52.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HHS/FHS REB 10-268
Identifier Type: -
Identifier Source: org_study_id